Personalised therapies are transforming the pharmaceutical landscape, offering treatments tailored to the needs of individual patients. For companies supporting the sector, keeping pace with these advancements is vital to ensure meaningful collaboration and continued innovation.
Business Platforms, a specialist consultancy and system integrator in Manufacturing and Supply Chain, recently partnered with BioPharmaChem Skillnet to upskill their team in this emerging area.
About Business Platforms
Business Platforms is a specialist consultancy and system integrator in Manufacturing and Supply Chain, with a dedicated focus on the pharmaceutical sector. The company enables operational excellence by orchestrating systems, processes, and people into a seamless enterprise layer. Best known for their expertise in MES, Business Platforms delivers end-to-end strategic solutions that support clients across the sector.
The Challenge
With personalised therapies rapidly advancing, Business Platforms recognised the importance of equipping their team with a deeper understanding of the science and processes behind this innovative field. The goal was to ensure their consultants could hold more meaningful conversations with the teams they support onsite every day.
The Solution
To bridge this knowledge gap, the team enrolled in BioPharmaChem Skillnet’s Certificate in CPD: Introduction to Biopharmaceuticals and Advanced Personalised Therapies.
The Learning Experience
The course content was detailed, practical, and directly relevant to the team’s roles. It gave them a stronger grasp of the complex manufacturing processes underpinning personalised therapies, enhancing their confidence and capability in client engagements.
The Impact
Following the course, Business Platforms’ consultants have been able to contribute significantly to process design and improvement with their clients, applying their new expertise to real-world challenges in the sector.
Testimonial
Preparing for the Future of Pharma
As personalised therapies become increasingly central to the pharmaceutical industry, targeted training ensures that professionals and organisations remain ahead of the curve.
The Certificate in CPD: Introduction to Biopharmaceuticals and Advanced Personalised Therapies (NFQ Level 8) introduces learners to the molecular and cellular basis of diseases and how they influence the design and manufacture of biological therapies.
The programme emphasises protein and vaccine-based treatments, while also exploring emerging gene and cell therapies along with personalised treatments. Delivered part-time and online, it offers flexibility with recorded lectures and practical, industry-relevant content.
Key Details
- Start Date: 25th September 2025
- Duration: 8 weeks of lectures (1 evening per week – Thursdays)
- Mode: Part-time, online (recordings available)
- Price: €875 per person (subsidised rate) | Actual price €1,250
- Bookings Close: 16th September 2025
📌 If your team is looking to build expertise in this critical area, explore the course today:
👉 Learn more about the Certificate in CPD: Introduction to Biopharmaceuticals and Advanced Personalised Therapies
